Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul;85(1):206-221.
doi: 10.1007/s12020-024-03724-4. Epub 2024 Feb 17.

The relationship between advanced liver fibrosis and osteoporosis in type 2 diabetes patients with MAFLD

Binjing Pan  1 , Yangting Zhao  1 , Chongyang Chen  1 , Jing Cai  1 , Kai Li  1 , Yawen Wang  1 , Jingfang Liu  2   3
Affiliations

The relationship between advanced liver fibrosis and osteoporosis in type 2 diabetes patients with MAFLD

Binjing Pan et al. Endocrine. 2024 Jul.

Abstract

Purpose: To investigate the relationship between advanced liver fibrosis and osteoporosis in metabolic-associated fatty liver disease (MAFLD) in patients with type 2 diabetes mellitus (T2DM).

Methods: A total of 1144 T2DM patients were divided into the MAFLD and non-MAFLD groups, 460 T2DM patients with MAFLD (277 males aged ≥50 years and 183 postmenopausal females) were divided into N1 (advanced liver fibrosis excluded), N2 (indeterminate advanced liver fibrosis), and N3 (advanced liver fibrosis) groups according to the non-alcoholic fatty liver fibrosis score (NFS), the differences in bone mineral density (BMD) levels and prevalence of osteoporosis were compared. Based on the tertile levels of BMD of the lumbar spine (L), T2DM patients were divided into three groups (T1, T2, and T3), and the differences in the prevalence of advanced liver fibrosis were compared.

Results: The BMD levels of the L4, and L1-4 in the MAFLD group were lower than those of the non-MAFLD groups in male and female T2DM patients .The BMD levels of the total hip, L4, and L1-4 in the N3 group were lower than those of the N2 and N1 groups in male and female T2DM patients with MAFLD, and the prevalence of osteoporosis in the N3 group of males was higher than that in the N1 group. The BMD levels of the total hip, L4, and L1-4 were negatively correlated with NFS in both males and females. The BMD levels of the total hip and L4 in males, and the BMD level of L4 in females were negatively associated with NFS. The prevalence of advanced liver fibrosis was higher in the T1 group than in the T2 and T3 groups in T2DM patients with MAFLD.

Conclusion: The BMD levels in male aged ≥50 years or postmenopausal female diabetic patients with MAFLD were negatively correlated with the degree of advanced liver fibrosis, which means an increased risk of liver fibrosis with decreasing BMD.

Keywords: Bone mineral density; Liver fibrosis; Metabolic - associated fatty liver disease; Osteoporosis; Type 2 diabetes mellitus.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. J. Maurice, P. Manousou, Non-alcoholic fatty liver disease. Clin. Med. 18, 245–250 (2018). https://doi.org/10.7861/clinmedicine.18-3-245 - DOI
    1. R.J. Wong, M. Aguilar, R. Cheung, R.B. Perumpail, S.A. Harrison, Z.M. Younossi, A. Ahmed, Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 148, 547–555 (2015). https://doi.org/10.1053/j.gastro.2014.11.039 - DOI - PubMed
    1. Z.M. Younossi, M.E. Rinella, A.J. Sanyal, S.A. Harrison, E.M. Brunt, Z. Goodman, D.E. Cohen, R. Loomba, From NAFLD to MAFLD: Implications of a Premature Change in Terminology. Hepatology 73, 1194–1198 (2021). https://doi.org/10.1002/hep.31420 - DOI - PubMed
    1. M. Eslam, P.N. Newsome, S.K. Sarin, Q.M. Anstee, G. Targher et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J. Hepatol. 73, 202–209 (2020). https://doi.org/10.1016/j.jhep.2020.03.039 - DOI - PubMed
    1. S. Lin, J. Huang, M. Wang, R. Kumar, Y. Liu, S. Liu, Y. Wu, X. Wang, Y. Zhu, Comparison of MAFLD and NAFLD diagnostic criteria in real world. Liver Int. 40, 2082–2089 (2020). https://doi.org/10.1111/liv.14548 - DOI - PubMed

MeSH terms

LinkOut - more resources